Gokverslaving: Wetenschappelijke inzichten, klinische realiteiten en ethische inzet …

Conference (2009, October 15)

Des dépendances qui nous enchainent aux liens qui nous déchainent

in Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles (2009), 11

Evidence that the Two-Way Communication Checklist identifies patient-doctor needs discordance resulting in better 6-month outcome.

in Acta Psychiatrica Scandinavica (2008), 118(4), 322-6

OBJECTIVE: To assess an intervention aimed at reducing patient-professional carer needs discordance. METHOD: In a group of 460 patients with schizophrenia, the Two-Way Communication Checklist (2-COM), an ... [more ▼]

OBJECTIVE: To assess an intervention aimed at reducing patient-professional carer needs discordance. METHOD: In a group of 460 patients with schizophrenia, the Two-Way Communication Checklist (2-COM), an instrument to rate needs, was completed at baseline, 2 months and 6 months by both the patient and the professional carer, allowing for the quantification of patient-carer needs discordance. RESULTS: Reduction in patient-reported 2-COM needs in the group with low baseline needs discordance was much greater at 2 and 6 months (2 months: beta = -0.65, P < 0.001; 6 months: beta = -1.00, P < 0.001) than in the group with high baseline discordance (2 months: beta = -0.35, P < 0.001; 6 months: beta = -0.49, P < 0.001). Reduction in needs discordance between baseline and 2 months (beta = -0.07, P = 0.004) as well between 2 and 6 months (beta = -0.05, P = 0.020) was associated with greater levels of CGI clinical improvement. CONCLUSION: The fact that patient-carer needs discordance impacts negatively, and its reduction positively, on 6-month outcome suggests that systematic inventory of patient-carer views on needs is necessary. [less ▲]

Un métier à tisser thérapeutique

in Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles (2008), 10

"Quand la dépression n'en finit pas... " Stratégies actuelles et perspectives thérapeutiques de la dépression résistante

in Revue Médicale de Liège (2007), 62(2), 103-11

All over the world, depression represents a major public health issue. According to WHO, it is the fifth disease in the world (in years of illness), the second for people aged 15 to 44 and by 2020, it ... [more ▼]

All over the world, depression represents a major public health issue. According to WHO, it is the fifth disease in the world (in years of illness), the second for people aged 15 to 44 and by 2020, it could become the second in the whole world population after cardiovascular diseases. Although increasingly safer and more efficient antidepressants are available, physicians are frequently confronted with the problem of resistant depression. Indeed, an estimated 30 to 45% of patients treated for major depressive disorder have either a partial response or no response at all to the antidepressive treatment. Residual symptoms are very common. Besides usual strategies such as lithium or thyroid hormones adding, some new approaches are now being used to improve the treatment of resistant depression. These are in particular pharmacological strategies such as switching or augmentation, psychotherapy and cerebral stimulation technology. This article reviews the latest clinical and therapeutic aspects of resistant depression. [less ▲]

Clinique du sujet et hyperspécialisation du soin en hôpital de jour: quand la réalité dépasse la fiction

in Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles (2007), 9

Dépression et maladies coronariennes: quand les émotions nous brisent le coeur...

in Revue Médicale de Liège (2005), 60(12), 931-8

Depression and cardiovascular diseases represent a major public health problem worldwide. Recent studies have shown that depression is a risk factor for the development of coronary artery disease (CAD) in ... [more ▼]

Depression and cardiovascular diseases represent a major public health problem worldwide. Recent studies have shown that depression is a risk factor for the development of coronary artery disease (CAD) in healthy people and also increases morbidity and mortality in depressed patients with CAD. Others studies have shown that selective serotonin inhibitors (SSRIs) constitute a safe and effective treatment for depressed patients with heart disease. There are also data suggesting that treating depression with SSRIs has a protective role in myocardial infarction and may improve outcomes, including mortality. [less ▲]

Urgences et crise d'aujourd'hui: quelle place pour l'hôpital de jour?

in Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles (2005), 7

L'hôpital de jour: théatre d'avant garde d'une psychothérapie institutionnelle en mouvement

in Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles (2004), 6

"Arrachez-moi ce coeur!": de la crainte du rejet au délire après transplantation cardiaque

in Revue Médicale de Liège (2002), 57(6), 389-92